According to Latest Study, the global market for Antiemetics for Cancer Treatment should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

China Antiemetics for Cancer Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

The United States Antiemetics for Cancer Treatment market should grow from US$ million in 2022 to US$ million by 2029, with a CAGR of % for the period of 2023-2029.

In terms of type, Serotonin Receptor Antagonists segment holds a share about % in 2022 and will reach % in 2029; while in terms of application, Highly Emetogenic Chemotherapy has a share approximately % in 2022 and will grow at a CAGR % during 2023 and 2029.

The global key manufacturers of Antiemetics for Cancer Treatment include Heron Therapeutics, Inc, Sandoz International GmbH, Merck & Co., Inc, Eisai Co., Ltd, Teva Pharmaceutical Industries Ltd, F. Hoffmann-La Roche Ltd, Mylan N.V, GSK plc and Mundipharma International, etc. In 2022, the global top five players hold a share approximately % in terms of revenue.

Emetogenic symptoms are associated with nausea and vomiting associated with cancer treatments such as chemotherapy, radiation therapy, and drug therapy. Nausea and vomiting are major side effects of cancer treatment. It is important that nausea and vomiting are controlled so patients can continue treatment and have a better quality of life. Nausea and vomiting, primarily due to, can also be induced in patients receiving chemotherapy and radiation therapy of the brain, gastrointestinal tract, or liver.

This report aims to provide a comprehensive study of the global market for Antiemetics for Cancer Treatment. Report Highlights:

(1) Global Antiemetics for Cancer Treatment market size (sales volume & revenue), history data from 2018-2022 and forecast data from 2023 to 2029.

(2) Global Antiemetics for Cancer Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(3) China Antiemetics for Cancer Treatment market competitive situation, sales, revenue, price and market share, from 2018 to 2022.

(4) Global Antiemetics for Cancer Treatment segment by region (or country), key regions cover the United States, Europe, Japan, South Korea, Southeast Asia and India, etc.

(5) Global Antiemetics for Cancer Treatment segment by type and by application and regional segment by type and by application.

(6) Global major production regions of Antiemetics for Cancer Treatment, capacity, production and trends.

(7) Antiemetics for Cancer Treatment industry supply chain, upstream, midstream and downstream analysis.

Market segment by regions, regional analysis covers

North America (United States, Canada and Mexico)

Europe (Germany, France, UK, Russia, Italy and Rest of Europe)

Asia-Pacific (China, Japan, South Korea, India, Southeast Asia, Australia and Rest of Asia-Pacific)

South America (Brazil, Rest of South America)

Middle East & Africa

Market segment by type, covers

Serotonin Receptor Antagonists

Neurokinin-1 Receptor Antagonist

Corticosteroids

Olanzapine

Other

Market segment by application, can be divided into

Highly Emetogenic Chemotherapy

Moderately Emetogenic Chemotherapy

Low Emetogenic Chemotherapy

Market segment by players, this report covers

Heron Therapeutics, Inc

Sandoz International GmbH

Merck & Co., Inc

Eisai Co., Ltd

Teva Pharmaceutical Industries Ltd

F. Hoffmann-La Roche Ltd

Mylan N.V

GSK plc

Mundipharma International

Baxter

Bayer AG

Cipla Inc

Sanofi

Sun Pharmaceutical Industries Ltd

Qilu Pharmaceutical Co.,Ltd

1 Market Overview

1.1 Antiemetics for Cancer Treatment Definition

1.2 Global Antiemetics for Cancer Treatment Market Size and Forecast

1.2.1 By Revenue, Global Antiemetics for Cancer Treatment Market Size, 2018-2029

1.2.2 By Sales Volume, Global Antiemetics for Cancer Treatment Market Size, 2018-2029

1.2.3 Global Antiemetics for Cancer Treatment Price Trend, 2018-2029

1.3 China Antiemetics for Cancer Treatment Market Size and Forecast

1.3.1 By Revenue, China Antiemetics for Cancer Treatment Market Size, 2018-2029

1.3.2 By Sales Volume, China Antiemetics for Cancer Treatment Market Size, 2018-2029

1.3.3 China Antiemetics for Cancer Treatment Price Trend, 2018-2029

1.4 China Percentage in Global Market

1.4.1 By Revenue, China Antiemetics for Cancer Treatment Share in Global Market, 2018-2029

1.4.2 By Sales Volume, China Antiemetics for Cancer Treatment Share in Global Market, 2018-2029

1.4.3 Antiemetics for Cancer Treatment Market Size: China VS Global, 2018-2029

1.5 Antiemetics for Cancer Treatment Market Dynamics

1.5.1 Antiemetics for Cancer Treatment Market Drivers

1.5.2 Antiemetics for Cancer Treatment Market Restraints

1.5.3 Antiemetics for Cancer Treatment Industry Trends

1.5.4 Antiemetics for Cancer Treatment Industry Policy

2 Global Competitive Landscape by Company

2.1 Global Antiemetics for Cancer Treatment Revenue by Company, 2018-2023

2.2 Global Antiemetics for Cancer Treatment Sales Volume by Company, 2018-2023

2.3 Global Antiemetics for Cancer Treatment Price by Company, 2018-2023

2.4 Global Antiemetics for Cancer Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)

2.5 Global Antiemetics for Cancer Treatment Concentration Ratio

2.6 Global Antiemetics for Cancer Treatment Mergers & Acquisitions, Expansion Plans

2.7 Global Antiemetics for Cancer Treatment Manufacturers Product Type

3 China Competitive Landscape by Company

3.1 China Antiemetics for Cancer Treatment Revenue by Company, 2018-2023

3.2 China Antiemetics for Cancer Treatment Sales Volume by Company, 2018-2023

3.3 China Antiemetics for Cancer Treatment Antiemetics for Cancer Treatment Participants, Market Position (Tier 1, Tier 2 and Tier 3)

3.4 China Antiemetics for Cancer Treatment Market, Sales Percentage of Local Players VS Foreign Players (2018-2023)

3.5 Chinese Local Players, Antiemetics for Cancer Treatment Domestic VS Export

3.6 China Market, Antiemetics for Cancer Treatment Import & Export

3.6.1 China Market, Antiemetics for Cancer Treatment Import & Export, 2018-2029

3.6.2 China Antiemetics for Cancer Treatment Import & Export Trends

3.6.3 Main Sources of China Antiemetics for Cancer Treatment Import

3.6.4 Export Destination of China Antiemetics for Cancer Treatment

4 Antiemetics for Cancer Treatment Production by Region

4.1 Global Antiemetics for Cancer Treatment Capacity, Production and Capacity Utilization, 2018-2029

4.2 Global Geographic Distribution of Antiemetics for Cancer Treatment Manufacturers

4.3 Global Major Manufacturers, Antiemetics for Cancer Treatment Capacity Expansion and Future Plans

4.4 Global Antiemetics for Cancer Treatment Capacity by Region

4.5 Global Antiemetics for Cancer Treatment Production by Region

4.5.1 Global Antiemetics for Cancer Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029

4.5.2 Global Antiemetics for Cancer Treatment Production by Region, 2018-2023

4.5.3 Global Antiemetics for Cancer Treatment Production Market Share & Forecast by Region, 2018-2029

5 Industry Chain Analysis

5.1 Antiemetics for Cancer Treatment Industry Chain

5.2 Antiemetics for Cancer Treatment Upstream Analysis

5.2.1 Antiemetics for Cancer Treatment Core Raw Materials

5.2.2 Main Manufacturers of Antiemetics for Cancer Treatment Core Raw Materials

5.3 Midstream Analysis

5.4 Downstream Analysis

5.5 Antiemetics for Cancer Treatment Production Mode

5.6 Antiemetics for Cancer Treatment Procurement Model

5.7 Antiemetics for Cancer Treatment Industry Sales Model and Sales Channels

5.7.1 Antiemetics for Cancer Treatment Sales Model

5.7.2 Antiemetics for Cancer Treatment Typical Distributors

6 Sights by Type

6.1 Antiemetics for Cancer Treatment Classification

6.1.1 Serotonin Receptor Antagonists

6.1.2 Neurokinin-1 Receptor Antagonist

6.1.3 Corticosteroids

6.1.4 Olanzapine

6.1.5 Other

6.2 By Type, Global Antiemetics for Cancer Treatment Market Size & CAGR, 2018 VS 2022 VS 2029

6.3 By Type, Global Antiemetics for Cancer Treatment Revenue, 2018-2029

6.4 By Type, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029

6.5 By Type, Global Antiemetics for Cancer Treatment Price, 2018-2029

7 Sights by Application

7.1 Antiemetics for Cancer Treatment Segment by Application

7.1.1 Highly Emetogenic Chemotherapy

7.1.2 Moderately Emetogenic Chemotherapy

7.1.3 Low Emetogenic Chemotherapy

7.2 By Application, Global Antiemetics for Cancer Treatment Market Size & CAGR, 2018 VS 2022 VS 2029

7.3 By Application, Global Antiemetics for Cancer Treatment Revenue, 2018-2029

7.4 By Application, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029

7.5 By Application, Global Antiemetics for Cancer Treatment Price, 2018-2029

8 Sales Sights by Region

8.1 By Region, Global Antiemetics for Cancer Treatment Market Size, 2018 VS 2022 VS 2029

8.2 By Region, Global Antiemetics for Cancer Treatment Revenue, 2018-2029

8.3 By Region, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029

8.4 North America

8.4.1 North America Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029

8.4.2 By Country, North America Antiemetics for Cancer Treatment Market Size Market Share

8.5 Europe

8.5.1 Europe Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029

8.5.2 By Country, Europe Antiemetics for Cancer Treatment Market Size Market Share

8.6 Asia Pacific

8.6.1 Asia Pacific Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029

8.6.2 By Country/Region, Asia Pacific Antiemetics for Cancer Treatment Market Size Market Share

8.7 South America

8.7.1 South America Antiemetics for Cancer Treatment Market Size & Forecasts, 2018-2029

8.7.2 By Country, South America Antiemetics for Cancer Treatment Market Size Market Share

8.8 Middle East & Africa

9 Sales Sights by Country Level

9.1 By Country, Global Antiemetics for Cancer Treatment Market Size & CAGR，2018 VS 2022 VS 2029

9.2 By Country, Global Antiemetics for Cancer Treatment Revenue, 2018-2029

9.3 By Country, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029

9.4 U.S.

9.4.1 U.S. Antiemetics for Cancer Treatment Market Size, 2018-2029

9.4.2 By Company, U.S. Antiemetics for Cancer Treatment Sales Volume Market Share, 2022

9.4.3 By Type, U.S. Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.4.4 By Application, U.S. Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.5 Europe

9.5.1 Europe Antiemetics for Cancer Treatment Market Size, 2018-2029

9.5.2 By Company, Europe Antiemetics for Cancer Treatment Sales Volume Market Share, 2022

9.5.3 By Type, Europe Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.5.4 By Application, Europe Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.6 China

9.6.1 China Antiemetics for Cancer Treatment Market Size, 2018-2029

9.6.2 By Company, China Antiemetics for Cancer Treatment Sales Volume Market Share, 2022

9.6.3 By Type, China Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.6.4 By Application, China Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.7 Japan

9.7.1 Japan Antiemetics for Cancer Treatment Market Size, 2018-2029

9.7.2 By Company, Japan Antiemetics for Cancer Treatment Sales Volume Market Share, 2022

9.7.3 By Type, Japan Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.7.4 By Application, Japan Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.8 South Korea

9.8.1 South Korea Antiemetics for Cancer Treatment Market Size, 2018-2029

9.8.2 By Company, South Korea Antiemetics for Cancer Treatment Sales Volume Market Share, 2022

9.8.3 By Type, South Korea Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.8.4 By Application, South Korea Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.9 Southeast Asia

9.9.1 Southeast Asia Antiemetics for Cancer Treatment Market Size, 2018-2029

9.9.2 By Company, Southeast Asia Antiemetics for Cancer Treatment Sales Volume Market Share, 2022

9.9.3 By Type, Southeast Asia Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.9.4 By Application, Southeast Asia Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.10 India

9.10.1 India Antiemetics for Cancer Treatment Market Size, 2018-2029

9.10.2 By Company, India Antiemetics for Cancer Treatment Sales Volume Market Share, 2022

9.10.3 By Type, India Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.10.4 By Application, India Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.11 Middle East & Asia

9.11.1 Middle East & Asia Antiemetics for Cancer Treatment Market Size, 2018-2029

9.11.2 By Company, Middle East & Asia Antiemetics for Cancer Treatment Sales Volume Market Share, 2022

9.11.3 By Type, Middle East & Asia Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

9.11.4 By Application, Middle East & Asia Antiemetics for Cancer Treatment Market Size, Share, 2022 VS 2029

10 Manufacturers Profile

10.1 Heron Therapeutics, Inc

10.1.1 Heron Therapeutics, Inc Company Information, Head Office, Market Area and Industry Position

10.1.2 Heron Therapeutics, Inc Antiemetics for Cancer Treatment Models, Specifications and Application

10.1.3 Heron Therapeutics, Inc Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.1.4 Heron Therapeutics, Inc Company Profile and Main Business

10.1.5 Heron Therapeutics, Inc Recent Developments

10.2 Sandoz International GmbH

10.2.1 Sandoz International GmbH Company Information, Head Office, Market Area and Industry Position

10.2.2 Sandoz International GmbH Antiemetics for Cancer Treatment Models, Specifications and Application

10.2.3 Sandoz International GmbH Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.2.4 Sandoz International GmbH Company Profile and Main Business

10.2.5 Sandoz International GmbH Recent Developments

10.3 Merck & Co., Inc

10.3.1 Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position

10.3.2 Merck & Co., Inc Antiemetics for Cancer Treatment Models, Specifications and Application

10.3.3 Merck & Co., Inc Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.3.4 Merck & Co., Inc Company Profile and Main Business

10.3.5 Merck & Co., Inc Recent Developments

10.4 Eisai Co., Ltd

10.4.1 Eisai Co., Ltd Company Information, Head Office, Market Area and Industry Position

10.4.2 Eisai Co., Ltd Antiemetics for Cancer Treatment Models, Specifications and Application

10.4.3 Eisai Co., Ltd Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.4.4 Eisai Co., Ltd Company Profile and Main Business

10.4.5 Eisai Co., Ltd Recent Developments

10.5 Teva Pharmaceutical Industries Ltd

10.5.1 Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

10.5.2 Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications and Application

10.5.3 Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.5.4 Teva Pharmaceutical Industries Ltd Company Profile and Main Business

10.5.5 Teva Pharmaceutical Industries Ltd Recent Developments

10.6 F. Hoffmann-La Roche Ltd

10.6.1 F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position

10.6.2 F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Models, Specifications and Application

10.6.3 F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.6.4 F. Hoffmann-La Roche Ltd Company Profile and Main Business

10.6.5 F. Hoffmann-La Roche Ltd Recent Developments

10.7 Mylan N.V

10.7.1 Mylan N.V Company Information, Head Office, Market Area and Industry Position

10.7.2 Mylan N.V Antiemetics for Cancer Treatment Models, Specifications and Application

10.7.3 Mylan N.V Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.7.4 Mylan N.V Company Profile and Main Business

10.7.5 Mylan N.V Recent Developments

10.8 GSK plc

10.8.1 GSK plc Company Information, Head Office, Market Area and Industry Position

10.8.2 GSK plc Antiemetics for Cancer Treatment Models, Specifications and Application

10.8.3 GSK plc Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.8.4 GSK plc Company Profile and Main Business

10.8.5 GSK plc Recent Developments

10.9 Mundipharma International

10.9.1 Mundipharma International Company Information, Head Office, Market Area and Industry Position

10.9.2 Mundipharma International Antiemetics for Cancer Treatment Models, Specifications and Application

10.9.3 Mundipharma International Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.9.4 Mundipharma International Company Profile and Main Business

10.9.5 Mundipharma International Recent Developments

10.10 Baxter

10.10.1 Baxter Company Information, Head Office, Market Area and Industry Position

10.10.2 Baxter Antiemetics for Cancer Treatment Models, Specifications and Application

10.10.3 Baxter Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.10.4 Baxter Company Profile and Main Business

10.10.5 Baxter Recent Developments

10.11 Bayer AG

10.11.1 Bayer AG Company Information, Head Office, Market Area and Industry Position

10.11.2 Bayer AG Antiemetics for Cancer Treatment Models, Specifications and Application

10.11.3 Bayer AG Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.11.4 Bayer AG Company Profile and Main Business

10.11.5 Bayer AG Recent Developments

10.12 Cipla Inc

10.12.1 Cipla Inc Company Information, Head Office, Market Area and Industry Position

10.12.2 Cipla Inc Antiemetics for Cancer Treatment Models, Specifications and Application

10.12.3 Cipla Inc Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.12.4 Cipla Inc Company Profile and Main Business

10.12.5 Cipla Inc Recent Developments

10.13 Sanofi

10.13.1 Sanofi Company Information, Head Office, Market Area and Industry Position

10.13.2 Sanofi Antiemetics for Cancer Treatment Models, Specifications and Application

10.13.3 Sanofi Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.13.4 Sanofi Company Profile and Main Business

10.13.5 Sanofi Recent Developments

10.14 Sun Pharmaceutical Industries Ltd

10.14.1 Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

10.14.2 Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications and Application

10.14.3 Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.14.4 Sun Pharmaceutical Industries Ltd Company Profile and Main Business

10.14.5 Sun Pharmaceutical Industries Ltd Recent Developments

10.15 Qilu Pharmaceutical Co.,Ltd

10.15.1 Qilu Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area and Industry Position

10.15.2 Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Models, Specifications and Application

10.15.3 Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Sales Volume, Revenue, Price and Gross Margin, 2018-2023

10.15.4 Qilu Pharmaceutical Co.,Ltd Company Profile and Main Business

10.15.5 Qilu Pharmaceutical Co.,Ltd Recent Developments

11 Conclusion

12 Appendix

12.1 Research Methodology

12.2 Data Source

12.2.1 Secondary Sources

12.2.2 Primary Sources

12.3 Market Estimation Model

12.4 Disclaimer

Table 1. Antiemetics for Cancer Treatment Market Size & CAGR: China VS Global, 2018-2029, US$ Million

Table 2. Antiemetics for Cancer Treatment Market Restraints

Table 3. Antiemetics for Cancer Treatment Market Trends

Table 4. Antiemetics for Cancer Treatment Industry Policy

Table 5. Global Antiemetics for Cancer Treatment Revenue by Company, 2018-2023, US$ million

Table 6. Global Antiemetics for Cancer Treatment Revenue Market Share by Company, 2018-2023

Table 7. Global Antiemetics for Cancer Treatment Sales Volume by Company, 2018-2023, (K Units)

Table 8. Global Antiemetics for Cancer Treatment Sales Volume Market Share by Company, 2018-2023

Table 9. Global Antiemetics for Cancer Treatment Price by Company, 2018-2023, (US$/Unit)

Table 10. Global Antiemetics for Cancer Treatment Manufacturers Market Concentration Ratio (CR3 and HHI)

Table 11. Global Antiemetics for Cancer Treatment Mergers & Acquisitions, Expansion Plans

Table 12. Global Antiemetics for Cancer Treatment Manufacturers Product Type

Table 13. China Antiemetics for Cancer Treatment Revenue by Company, 2018-2023, US$ million

Table 14. China Antiemetics for Cancer Treatment Revenue Market Share by Company, 2018-2023

Table 15. China Antiemetics for Cancer Treatment Sales Volume by Company, 2018-2023, (K Units)

Table 16. China Antiemetics for Cancer Treatment Sales Volume Market Share by Company, 2018-2023

Table 17. China Market, Antiemetics for Cancer Treatment Production, Sales, Import and Export, 2018-2029, (K Units)

Table 18. China Antiemetics for Cancer Treatment Import & Export Trends

Table 19. Main Sources of China Antiemetics for Cancer Treatment Import

Table 20. Export Destination of China Antiemetics for Cancer Treatment

Table 21. Global Headquarters and Manufacturing Base of Antiemetics for Cancer Treatment Manufacturers

Table 22. Global Major Manufacturers, Antiemetics for Cancer Treatment Capacity Expansion and Future Plans

Table 23. Global Antiemetics for Cancer Treatment Production & Forecast by Region, 2018 VS 2022 VS 2029, (K Units)

Table 24. Global Antiemetics for Cancer Treatment Production by Region, 2018-2023, (K Units)

Table 25. Global Antiemetics for Cancer Treatment Production Forecast by Region, 2023-2029, (K Units)

Table 26. Global Key Players of Antiemetics for Cancer Treatment Upstream (Raw Materials)

Table 27. Global Antiemetics for Cancer Treatment Typical Customers

Table 28. Antiemetics for Cancer Treatment Typical Distributors

Table 29. By Type, Global Antiemetics for Cancer Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 30. By Application, Global Antiemetics for Cancer Treatment Revenue & CAGR, 2018 VS 2022 VS 2029, US$ Million

Table 31. By Region, Global Antiemetics for Cancer Treatment Market Size, 2018 VS 2022 VS 2029, US$ Million

Table 32. By Region, Global Antiemetics for Cancer Treatment Revenue, 2018-2029, US$ Million

Table 33. By Region, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029, (K Units)

Table 34. By Country, Global Antiemetics for Cancer Treatment Revenue & CAGR，2018 VS 2022 VS 2029, US$ Million

Table 35. By Country, Global Antiemetics for Cancer Treatment Revenue, 2018-2029, US$ Million

Table 36. By Country, Global Antiemetics for Cancer Treatment Revenue Market Share, 2018-2029

Table 37. By Country, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029, (K Units)

Table 38. By Country, Global Antiemetics for Cancer Treatment Sales Volume Market Share, 2018-2029

Table 39. Heron Therapeutics, Inc Company Information, Head Office, Market Area and Industry Position

Table 40. Heron Therapeutics, Inc Antiemetics for Cancer Treatment Models, Specifications and Application

Table 41. Heron Therapeutics, Inc Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 42. Heron Therapeutics, Inc Company Profile and Main Business

Table 43. Heron Therapeutics, Inc Recent Developments

Table 44. Sandoz International GmbH Company Information, Head Office, Market Area and Industry Position

Table 45. Sandoz International GmbH Antiemetics for Cancer Treatment Models, Specifications and Application

Table 46. Sandoz International GmbH Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 47. Sandoz International GmbH Company Profile and Main Business

Table 48. Sandoz International GmbH Recent Developments

Table 49. Merck & Co., Inc Company Information, Head Office, Market Area and Industry Position

Table 50. Merck & Co., Inc Antiemetics for Cancer Treatment Models, Specifications and Application

Table 51. Merck & Co., Inc Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 52. Merck & Co., Inc Company Profile and Main Business

Table 53. Merck & Co., Inc Recent Developments

Table 54. Eisai Co., Ltd Company Information, Head Office, Market Area and Industry Position

Table 55. Eisai Co., Ltd Antiemetics for Cancer Treatment Models, Specifications and Application

Table 56. Eisai Co., Ltd Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 57. Eisai Co., Ltd Company Profile and Main Business

Table 58. Eisai Co., Ltd Recent Developments

Table 59. Teva Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

Table 60. Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications and Application

Table 61. Teva Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 62. Teva Pharmaceutical Industries Ltd Company Profile and Main Business

Table 63. Teva Pharmaceutical Industries Ltd Recent Developments

Table 64. F. Hoffmann-La Roche Ltd Company Information, Head Office, Market Area and Industry Position

Table 65. F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Models, Specifications and Application

Table 66. F. Hoffmann-La Roche Ltd Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 67. F. Hoffmann-La Roche Ltd Company Profile and Main Business

Table 68. F. Hoffmann-La Roche Ltd Recent Developments

Table 69. Mylan N.V Company Information, Head Office, Market Area and Industry Position

Table 70. Mylan N.V Antiemetics for Cancer Treatment Models, Specifications and Application

Table 71. Mylan N.V Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 72. Mylan N.V Company Profile and Main Business

Table 73. Mylan N.V Recent Developments

Table 74. GSK plc Company Information, Head Office, Market Area and Industry Position

Table 75. GSK plc Antiemetics for Cancer Treatment Models, Specifications and Application

Table 76. GSK plc Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 77. GSK plc Company Profile and Main Business

Table 78. GSK plc Recent Developments

Table 79. Mundipharma International Company Information, Head Office, Market Area and Industry Position

Table 80. Mundipharma International Antiemetics for Cancer Treatment Models, Specifications and Application

Table 81. Mundipharma International Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 82. Mundipharma International Company Profile and Main Business

Table 83. Mundipharma International Recent Developments

Table 84. Baxter Company Information, Head Office, Market Area and Industry Position

Table 85. Baxter Antiemetics for Cancer Treatment Models, Specifications and Application

Table 86. Baxter Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 87. Baxter Company Profile and Main Business

Table 88. Baxter Recent Developments

Table 89. Bayer AG Company Information, Head Office, Market Area and Industry Position

Table 90. Bayer AG Antiemetics for Cancer Treatment Models, Specifications and Application

Table 91. Bayer AG Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 92. Bayer AG Company Profile and Main Business

Table 93. Bayer AG Recent Developments

Table 94. Cipla Inc Company Information, Head Office, Market Area and Industry Position

Table 95. Cipla Inc Antiemetics for Cancer Treatment Models, Specifications and Application

Table 96. Cipla Inc Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 97. Cipla Inc Company Profile and Main Business

Table 98. Cipla Inc Recent Developments

Table 99. Sanofi Company Information, Head Office, Market Area and Industry Position

Table 100. Sanofi Antiemetics for Cancer Treatment Models, Specifications and Application

Table 101. Sanofi Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 102. Sanofi Company Profile and Main Business

Table 103. Sanofi Recent Developments

Table 104. Sun Pharmaceutical Industries Ltd Company Information, Head Office, Market Area and Industry Position

Table 105. Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Models, Specifications and Application

Table 106. Sun Pharmaceutical Industries Ltd Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 107. Sun Pharmaceutical Industries Ltd Company Profile and Main Business

Table 108. Sun Pharmaceutical Industries Ltd Recent Developments

Table 109. Qilu Pharmaceutical Co.,Ltd Company Information, Head Office, Market Area and Industry Position

Table 110. Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Models, Specifications and Application

Table 111. Qilu Pharmaceutical Co.,Ltd Antiemetics for Cancer Treatment Sales Volume (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin, 2018-2023

Table 112. Qilu Pharmaceutical Co.,Ltd Company Profile and Main Business

Table 113. Qilu Pharmaceutical Co.,Ltd Recent Developments

List of Figure

Figure 1. Antiemetics for Cancer Treatment Picture

Figure 2. By Revenue, Global Antiemetics for Cancer Treatment Market Size and Forecast, 2018-2029, US$ Million

Figure 3. By Sales Volume, Global Antiemetics for Cancer Treatment Market Size and Forecast, 2018-2029, (K Units)

Figure 4. Global Antiemetics for Cancer Treatment Price Trend, 2018-2029, (US$/Unit)

Figure 5. By Revenue, China Antiemetics for Cancer Treatment Market Size and Forecast, 2018-2029, US$ million

Figure 6. By Sales Volume, China Antiemetics for Cancer Treatment Market Size and Forecast, 2018-2029, (K Units)

Figure 7. China Antiemetics for Cancer Treatment Price Trend, 2018-2029 (US$/Unit)

Figure 8. By Revenue, China Antiemetics for Cancer Treatment Share of Global Market, 2018-2029

Figure 9. By Sales Volume, China Antiemetics for Cancer Treatment Share of Global Market, 2018-2029

Figure 10. Global Antiemetics for Cancer Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 11. Global Antiemetics for Cancer Treatment Market Share by Company, (Tier 1, Tier 2 and Tier 3), 2022

Figure 12. China Antiemetics for Cancer Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 13. China Antiemetics for Cancer Treatment Key Participants, Market Share, 2021 VS 2022 VS 2023

Figure 14. China Antiemetics for Cancer Treatment Revenue, Domestic VS Import Products, Proportion of China Local Players and Foreign Players, 2018-2023

Figure 15. Chinese Local Players, Proportion of Antiemetics for Cancer Treatment Domestic VS Export, 2022

Figure 16. Global Antiemetics for Cancer Treatment Capacity, Production and Capacity Utilization, 2018-2029

Figure 17. Global Antiemetics for Cancer Treatment Capacity Market Share by Region, 2022 VS 2029

Figure 18. Global Antiemetics for Cancer Treatment Production Market Share & Forecast by Region, 2018-2029

Figure 19. Antiemetics for Cancer Treatment Industry Chain

Figure 20. Antiemetics for Cancer Treatment Procurement Model

Figure 21. Antiemetics for Cancer Treatment Sales Model

Figure 22. Antiemetics for Cancer Treatment Sales Channels, Direct Sales and Distribution

Figure 23. Serotonin Receptor Antagonists

Figure 24. Neurokinin-1 Receptor Antagonist

Figure 25. Corticosteroids

Figure 26. Olanzapine

Figure 27. Other

Figure 28. By Type, Global Antiemetics for Cancer Treatment Revenue, 2018-2029, US$ Million

Figure 29. By Type, Global Antiemetics for Cancer Treatment Revenue Market Share, 2018-2029

Figure 30. By Type, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029, (K Units)

Figure 31. By Type, Global Antiemetics for Cancer Treatment Sales Volume Market Share, 2018-2029

Figure 32. By Type, Global Antiemetics for Cancer Treatment Price, 2018-2029, (US$/Unit)

Figure 33. Highly Emetogenic Chemotherapy

Figure 34. Moderately Emetogenic Chemotherapy

Figure 35. Low Emetogenic Chemotherapy

Figure 36. By Application, Global Antiemetics for Cancer Treatment Revenue, 2018-2029, US$ Million

Figure 37. By Application, Global Antiemetics for Cancer Treatment Revenue Market Share, 2018-2029

Figure 38. By Application, Global Antiemetics for Cancer Treatment Sales Volume, 2018-2029, (K Units)

Figure 39. By Application, Global Antiemetics for Cancer Treatment Sales Volume Market Share, 2018-2029

Figure 40. By Application, Global Antiemetics for Cancer Treatment Price, 2018-2029, (US$/Unit)

Figure 41. By Region, Global Antiemetics for Cancer Treatment Revenue Market Share, 2018-2029

Figure 42. By Region, Global Antiemetics for Cancer Treatment Sales Volume Market Share, 2018-2029

Figure 43. North America Antiemetics for Cancer Treatment Revenue & Foreca